Trials / Completed
CompletedNCT02440178
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia
Phase II Trial of Micafungin Prophylaxis During Induction Chemotherapy for Patients With Acute Leukemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether prophylaxis with micafungin is effective in the induction chemotherapy for newly diagnosed acute leukemia patients.
Detailed description
Medically fit patients with newly diagnosed acute leukemia received 50 mg micafungin intravenously once daily from the initiation of first induction chemotherapy to recovery of neutrophil count, suspected fungal infection, or unacceptable drug-related toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Micafungin |
Timeline
- Start date
- 2015-09-19
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2015-05-12
- Last updated
- 2021-11-09
- Results posted
- 2021-11-09
Source: ClinicalTrials.gov record NCT02440178. Inclusion in this directory is not an endorsement.